<DOC>
	<DOC>NCT00700986</DOC>
	<brief_summary>The purpose of the study is to determine whether treatment with a single 800mg dose of AZD9056, a medication which has been developed as a possible treatment for Rheumatoid Arthritis, has an effect on the function of the retina</brief_summary>
	<brief_title>Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>Volunteers must be able to undergo the Electroretinography assessments Volunteers must have an intra ocular pressure of less than 25mmHg and 6/6 vision Volunteers must pass a test that assesses whether they are at risk of narrow angle glaucoma Volunteers must not a family history of colour blindness, they must also pass a colour blindness test Volunteers must not have a history or current neurological or opthalmological (eye) disease</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Electroretinography</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Anti-TNF</keyword>
	<keyword>Disease Modifying Anti-Rheumatic Drugs (DMARD)</keyword>
</DOC>